all report title image
  • Published In : Mar 2024
  • Code : CMI6792
  • Pages : 163
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
Ingographics Image

The global type 2 diabetes market is estimated to be valued at USD 39.87 BN in 2024 and is expected to exhibit a CAGR of 7.7% during the forecast period (2024-2031). Type 2 diabetes is a chronic metabolic disease characterized by high blood sugar levels due to insulin resistance or relative lack of insulin. It is the most common form of diabetes accounting for over 90% of all diagnosed cases of diabetes worldwide. The disease is a major global public health concern due to its rising prevalence driven by increasing obesity levels as well as aging populations across both developed and developing countries. The market size for type 2 diabetes management and treatment is vast and growing steadily. Current therapeutic options aim to lower blood sugar levels by increasing the body’s sensitivity to insulin, reducing glucose production in the liver, delaying glucose absorption from the intestine, or increasing insulin secretion from the remaining functioning beta cells.

Market Dynamics:

The global type 2 diabetes market is primarily driven by the increasing prevalence of obesity and low physical activity levels especially among urban populations leading to the rising incidence of type 2 diabetes. According to an article published by the Centers for Disease Control and Prevention in April 2023, about 38 million individuals in the U.S. are affected by diabetes, representing roughly one out of every 10 people. Approximately 90-95% of these cases are classified as type 2 diabetes. While type 2 diabetes traditionally manifests in individuals aged 45 and older, there is a growing trend of its occurrence among children, teenagers, and young adults. Increased research efforts to develop more effective medications with fewer side effects also present significant growth opportunities. However, high costs associated with diabetes care and management inhibits broader access to treatment in low and middle-income countries. Stringent regulations and long drug approval timelines also pose challenges.

Key Features of the Study:

  • This report provides an in-depth analysis of the global type 2 diabetes market, and provides market size (USD BN) and compound annual growth rate (CAGR %) for the forecast period (2024–2031), considering 2023 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global type 2 diabetes market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Novo Nordisk, Sanofi, Eli Lilly and Company, Merck & Co., Inc., Boehringer Ingelheim, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Novartis AG, GlaxoSmithKline plc, Pfizer Inc., Daiichi Sankyo Company, Limited, Abbott Laboratories, Roche Holding AG, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, and Torrent Pharmaceuticals Limited
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global type 2 diabetes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global type 2 diabetes market

Market Segmentation

  • By Drug Class:
    • Dipeptidyl Peptidase-4 Inhibitors
    • Glucagon-like peptide 1 receptor agonists
    • Biguanides 
    • Sodium-glucose cotransporter 2 (SGLT2) inhibitors
    • Others
  • By Route of Administration:
    • Oral
    • Parenteral
  • By End User:
    • Homecare Settings
    • Hospitals & Clinics
    • Academic & Research Institutes
    • Others
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Novo Nordisk
    • Sanofi
    • Eli Lilly and Company
    • Merck & Co., Inc.
    • Boehringer Ingelheim
    • AstraZeneca PLC
    • Takeda Pharmaceutical Company Limited
    • Novartis AG
    • GlaxoSmithKline plc
    • Pfizer Inc.
    • Daiichi Sankyo Company, Limited
    • Abbott Laboratories
    • Roche Holding AG
    • Sun Pharmaceutical Industries Ltd.
    • Lupin Limited
    • Reddy's Laboratories Ltd.
    • Aurobindo Pharma Limited
    • Torrent Pharmaceuticals Limited

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug Class
      • Market Snapshot, By Route of Administration
      • Market Snapshot, By End User
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Recent Developments
    • Acquisitions and Partnerships Scenario
    • Technology Overview
    • Regulatory Scenario
    • Pricing Analysis
    • PEST Analysis
  4. Global Type 2 Diabetes Market - Impact of Coronavirus (COVID-19) Pandemic
    • Overall Impact
    • Government Initiatives
    • COVID-19 impact on the market
  5. Global Type 2 Diabetes Market, By Drug Class, 2019 – 2031, (USD BN)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Dipeptidyl Peptidase-4 Inhibitors
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Glucagon-like peptide 1 receptor agonists
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Biguanides 
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Sodium-glucose cotransporter 2 (SGLT2) inhibitors
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Others 
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
  6. Global Type 2 Diabetes Market, By Route of Administration, 2019 – 2031, (USD BN)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Oral
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Parenteral
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
  7. Global Type 2 Diabetes Market, By End User, 2019 – 2031, (USD BN)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Homecare Settings
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Hospitals & Clinics
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Academic & Research Institutes
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
  8. Global Type 2 Diabetes Market, By Distribution Channel, 2019 – 2031, (USD BN)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Hospital Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Retail Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Online Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
  9. Global Type 2 Diabetes Market, By Region, 2019 – 2031, (USD BN)
    • Introduction
      • Market Share Analysis, By Region, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, For Region, 2020–2031
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD BN)
        • North Africa
        • Central Africa
        • South Africa
  10. Competitive Landscape
    • Company Profiles
      • Novo Nordisk*
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Sanofi
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Eli Lilly and Company
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Merck & Co., Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Boehringer Ingelheim
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • AstraZeneca PLC
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Takeda Pharmaceutical Company Limited
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Novartis AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • GlaxoSmithKline plc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Pfizer Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Daiichi Sankyo Company, Limited
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Roche Holding AG 
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sun Pharmaceutical Industries Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Lupin Limited
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Dr. Reddy's Laboratories Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Aurobindo Pharma Limited
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Torrent Pharmaceuticals Limited 
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  11. Analyst View
    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  12. References and Research Methodology
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 36 market data tables and 48 figures on "Global Type 2 Diabetes Market” – Global forecast to 2031

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo